...
首页> 外文期刊>Investigative ophthalmology & visual science >MicroRNA-146 inhibits thrombin-induced NF-κB activation and subsequent inflammatory responses in human retinal endothelial cells
【24h】

MicroRNA-146 inhibits thrombin-induced NF-κB activation and subsequent inflammatory responses in human retinal endothelial cells

机译:MicroRNA-146抑制凝血酶诱导的人视网膜内皮细胞中的NF-κB活化和随后的炎症反应

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE. Nuclear factor-jB (NF-κB), a key regulator of immune and inflammatory responses, plays important roles in diabetes-induced microvascular complications including diabetic retinopathy (DR). Thrombin activates NF-κB through protease-activated receptor (PAR)-1, a member of the G-protein-coupled receptor (GPCR) superfamily, and contributes to DR. The current study is to uncover the roles of microRNA (miRNA) in thrombin-induced NF-κB activation and retinal endothelial functions. METHODS. Target prediction was performed using the TargetScan algorithm. Predicted target was experimentally validated by luciferase reporter assays. Human retinal endothelial cells (HRECs) were transfected with miRNA mimics or antimiRs and treated with thrombin. Expression levels of miR-146 and related protein-coding genes were analyzed by quantitative (q)RT-PCR. Functional changes of HRECs were analyzed by leukocyte adhesion assays. RESULTS. We identified that caspase-recruitment domain (CARD)-containing protein 10 (CARD10), an essential scaffold/adaptor protein of GPCR-mediated NF-κB activation pathway, is a direct target of miR-146. Thrombin treatment resulted in NF-κB-dependent upregulation of miR-146 in HRECs; while transfection of miR-146 mimics resulted in significant downregulation of CARD10 and prevented thrombin-induced NF-κB activation, suggest that a negative feedback regulation of miR-146 on thrombin-induced NF-κB through targeting CARD10. Furthermore, overexpression of miR-146 prevented thrombin-induced increased leukocyte adhesion to HRECs. CONCLUSIONS. We uncovered a novel negative feedback regulatory mechanism on thrombininduced GPCR-mediated NF-κB activation by miR-146. In combination with the negative feedback regulation of miR-146 on the IL-1R/toll-like receptor (TLR)-mediated NF-κB activation in RECs that we reported previously, our results underscore a pivotal, negative regulatory role of miR-146 on multiple NF-κB activation pathways and related inflammatory processes in DR.
机译:目的。核因子-jB(NF-κB)是免疫和炎症反应的关键调节剂,在糖尿病引起的微血管并发症(包括糖尿病性视网膜病(DR))中起重要作用。凝血酶通过蛋白酶激活受体(PAR)-1(G蛋白偶联受体(GPCR)超家族的成员)激活NF-κB,并有助于DR。当前的研究是揭示微小RNA(miRNA)在凝血酶诱导的NF-κB激活和视网膜内皮功能中的作用。方法。使用TargetScan算法执行目标预测。预测的目标通过荧光素酶报告基因实验进行了实验验证。用miRNA模拟物或抗miRs转染人视网膜内皮细胞(HREC),并用凝血酶处理。通过定量(q)RT-PCR分析miR-146和相关蛋白编码基因的表达水平。 HRECs的功能变化通过白细胞粘附测定进行了分析。结果。我们鉴定到,含有半胱天冬酶募集结构域(CARD)的蛋白质10(CARD10),是GPCR介导的NF-κB激活途径的必需支架/适配器蛋白,是miR-146的直接目标。凝血酶治疗导致HREC中miR-146的NF-κB依赖性上调; miR-146模拟物的转染导致CARD10的显着下调并阻止了凝血酶诱导的NF-κB活化,这表明miR-146通过靶向CARD10对凝血酶诱导的NF-κB负反馈调节。此外,miR-146的过表达可防止凝血酶诱导的白细胞与HREC的粘附增加。结论。我们发现了miR-146对凝血酶诱导的GPCR介导的NF-κB活化的新型负反馈调节机制。结合我们先前报道的RECs中miR-146对IL-1R / toll样受体(TLR)介导的NF-κB激活的负反馈调节,我们的结果强调了miR-146的关键负调节作用在DR中有多种NF-κB激活途径和相关的炎症过程

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号